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A report on the 15th Biennial International C. elegans
Conference, Los Angeles, USA, 25-29 June 2005.
Since it was first described in 1900 by E. Maupas and chosen
in the late 1960s by Sydney Brenner as a species for genetic
study, the nematode Caenorhabditis elegans has come a
long way. The ‘worm’ has made innumerable contributions
to biology, including a deep understanding of the processes
of organ development and programmed cell death. At the
biennial international conference on C. elegans held in Los
Angeles in June, more than 2,000 researchers met to discuss
their newest findings covering all of worm biology (abstracts
are available at [http://www.genetics-gsa.org/genetics/
Celegans]). Here we will highlight progress in the areas of
functional genomics, RNA interference (RNAi) and related
phenomena, and evolutionary studies. 
Large-scale approaches: genomics and other
‘omics’
The genome of C. elegans was the first metazoan genome to
be sequenced and the worm is likely to be the first multicel-
lular organism for which deletion mutations in all confirmed
and predicted genes will be available. Mark Edgley from the
C. elegans Gene Knockout Consortium (Oklahoma Medical
Research Foundation, Oklahoma City, USA), and Shohei
Mitani (Women’s Medical University School of Medicine,
Tokyo, Japan), from Japan’s National Bioresource Project
on C. elegans, reported that their groups have together gen-
erated over 3,000 deletion mutants, representing about 15%
of known genes. Ronald Plasterk (Hubrecht Laboratory,
Utrecht, The Netherlands) described the construction of a
clonal library from 6,000 mutagenized worms that is being
directly sequenced for mutations in genes of interest. He
estimated that, using this technique, nonsense mutations in
essentially all worm genes would be identified in the next
two years.
Philippe Lamesch (Harvard Medical School, Boston, USA)
described progress towards the completion of the ORFeome
resource, an effort to clone all C. elegans open reading frames
(ORFs) into Gateway vectors. C. elegans has some 22,800 pre-
dicted genes, and so far, 12,500 ORFs have been cloned. Jean-
François Rual (also at Harvard Medical School) described the
beginning of a extensive series of yeast two-hybrid experi-
ments at Harvard, which will use this ORFeome resource to
build a complete map of interactions among the proteins
expressed by 11,000 of the ORFs in the ORFeome project. This
worm interactome map builds on an earlier version that
revealed about 5,500 potential protein-protein interactions.
Also making use of the ORFeome, Denis Dupuy and col-
leagues at Harvard Medical School have begun work on the
C. elegans localizome project with the stated goal of generat-
ing maps of gene expression and protein localization for most
genes throughout the different developmental stages.
A  C. elegans  hermaphrodite consists of only 959 somatic
cells; this is ideal for tracking individual cells during devel-
opment but poses challenges when researchers want to
determine the gene-expression profile of individual tissues,
many of which are composed of just a few cells. In indepen-
dent studies Rebecca Fox (Vanderbilt University, Nashville,
USA) and Kim Wong (Genome Sciences Center, Vancouver,
Canada) used tissue-specific green fluorescent protein (GFP)
reporters together with fluorescence-activated cell sorting
(FACS) followed by microarrays or serial analysis of gene
expression (SAGE), respectively, to tackle this problem. Fox
reported on the profiling of cells from the embryonic motor
circuit, where she not only found genes already known to be
expressed there, but also discovered a large number ofG-protein-coupled receptors not previously known to be
expressed in these cells. Wong constructed SAGE libraries
from a variety of tissues, including muscle, gut, hypodermis
and oocytes, and was able to detect over 400 different tran-
scription factors in the developing embryos.
Double-mutant suppression (or enhancement) studies of
synthetic interactions between two genes using whole-
genome RNAi screening in mutant backgrounds reveal novel
functions for genes that are missed in most forward genetic
studies, where commonly just a single gene is perturbed.
Andrew Fraser (The Wellcome Trust, Sanger Institute, Cam-
bridge, UK) described the development of a highly auto-
mated system that allows around 1,200 genetic interactions
to be probed in a day. Fraser is using this high-throughput
system to identify ‘interactor’ genes that are synthetic lethal
with genes of interest. One of the interacting pairs identified
is efl-1 (the worm equivalent of the transcriptional regulator
E2F) and lin-35 (the equivalent of the retinoblastoma
protein Rb).
RNA interference and microRNAs
RNAi was initially discovered in C. elegans and much of our
understanding of its mechanism comes from studies in the
worm. At the meeting it became clear that worms have still
more to offer. Testing individual candidate genes, Nathaniel
Dudley (University of North Carolina, Chapel Hill, USA)
reported the identification of six new genes, including genes
for chromatin-associated factors, that are required for RNAi.
In contrast, John Kim (Harvard Medical School) has under-
taken a genome-wide screen to identify genes required for
RNAi and has identified 90, including Piwi/PAZ proteins,
DEAH helicases, RNA-binding/processing factors, and chro-
matin-associated factors, among others. Thomas Duchaîne
(University of Massachusetts Medical School, Worcester,
USA) described a biochemical approach to identifying pro-
teins that interact with DCR-1 (Dicer) using multidimen-
sional protein identification technology (MudPIT) and has
found known and novel proteins that act negatively and pos-
itively on RNAi as determined by mutant analysis, as well as
proteins involved in the microRNA (miRNA) pathway. Three
independent groups are examining the role of RNAi as an
antiviral mechanism in C. elegans and have set up in vitro
systems for infection of C. elegans  cells. Morris Maduro
(University of California, Riverside, USA), Courtney Wilkins
(University of Arkansas, Little Rock, USA) and Daniel Schott
(Harvard University, Cambridge, USA) reported that the
cells respond by silencing the expression of exogenous RNA
and that the silencing is compromised in RNAi-deficient
mutant cells. 
The most surprising of the presentations on miRNAs came
from Shveta Bagga (University of California, San Diego,
USA). She challenged the view that miRNAs regulate their
targets at the translational level, and suggested that much of
the regulation is occurring at the mRNA level. Bagga found
that mRNA levels of the let-7 miRNA target lin-41 decrease
markedly when let-7 is expressed, but that there is no change
in mRNA levels in a let-7 mutant background. Similar results
were observed for the miRNA lin-4 and one of its targets.
Further work will be needed to determine if the effects seen
are caused directly by the miRNAs and to establish the gen-
erality of these findings with respect to other miRNAs and
organisms.
Evolutionary comparisons 
With the genomes of C. elegans and the related species
C. briggsae  sequenced and assembled, and with another
eight nematode species in the pipeline, worms provide a
robust platform for comparative genomics and evolutionary
studies. Sheldon McKay (Cold Spring Harbor Laboratory,
USA) presented an update on genome-wide sequence analy-
ses and new computational tools for comparative genome
analysis using C. elegans,  C. briggsae  and  C. remanei
sequences. The C. remanei sequence is currently being
assembled. McKay’s initial findings reveal surprising conser-
vation of synteny and colinearity among the three genomes,
in addition to conservation of operon structures. Ray Hong
(Max-Planck Institute for Developmental Biology, Tübingen,
Germany) reported on the current status of the genome-
sequencing project on the nematode Pristionchus pacificus,
which has reached 1x coverage. Karin Kiontke (New York
University, USA) described a phylogenetic study using
sequences of three nuclear genes of 47 nematode species in
the order Rhabditida and their relatives, which led her to
propose that hermaphroditism evolved independently at
least ten times from species with males and females. Kiontke
also presented support for the inclusion of the model organ-
ism  P. pacificus in the Rhabditida. Marie-Anne Felix
(Pasteur Institute, Paris, France) presented a detailed study
on the evolution of vulval patterning in the genus
Caenorhabditis down to the level of molecular pathways
involving a Ras signaling cascade. Finally, Min Hua Xiao
(also at the Max-Planck Institute for Developmental Biology)
reported surprising differences in the role of Wnt signaling
during vulva induction in C. elegans as compared to P. paci-
ficus, and described the introduction of antisense mor-
pholino oligonucleotides as a new tool for functional
genetics studies in P. pacificus.
With a rich toolkit including multiple genome sequences,
ways of generating high-throughput knockouts, and whole-
genome RNAi screens, C. elegans is poised to make major
contributions to the various research trends currently
described as ‘systems biology’. In recent years the worm has
given us RNAi and short RNAs, what can we expect next?
358.2 Genome Biology 2005, Volume 6, Issue 11, Article 358 Alvarez-Saavedra and Miska http://genomebiology.com/2005/6/11/358
Genome Biology 2005, 6:358